CARSON CITY, Nev., June 24, 2025 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that a poster highlighting the decentralized design and patient experience of its Phase 2 SUNRISE-PD clinical trial evaluating bezisterim (NE3107) in early Parkinson’s disease will be presented in poster session at the upcoming Adv ...

[Musica] [Musica] Buonasera. Buonasera. Grazie a tutti.È un onore per me essere qui e cercherò in questi in questi minuti di presentarvi la bellezza del di quello che ho trovato nel mio mondo. Avete mai pensato che il luogo più fantastico, più visionario, più irraggiungibile in realtà sia già dentro di noi. Eh, non è una galassia lontana, non è un'intelligenza artificiale, non è nemmeno un multiverso, ma è un cervello umano.Eh, io lo vedo ogni giorno, lo studio, lo tocco, lo opero. Io, come avete sentito, s ...

Mr. Cline brings extensive commercial expertise to lead the transition of Xenon to a commercial-stage company with the anticipated launch of azetukalner across three potential indicationsVANCOUVER, British Columbia and BOSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced the appointment of Darren Cline as Chief ...

June 24, 2025 7:00 AM EDT | Source: InMed Pharmaceuticals Vancouver, British Columbia--(Newsfile Corp. - June 24, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced new preclinical data demonstrating that INM-901 significantly reduces inflammation in ex vivo models of neuroinflammation, further supporting its potential a ...

[Música] Muito boa tarde, super poderosos. Que prazer estar aqui com vocês hoje. É uma honra para mim poder falar de um tema no qual eu acredito tanto, que é tão transformador, como ativar os seus superperes.Mas antes disso, eu quero trazer para vocês a história de um superherói, do meu superherói, do meu pai, Senr. Carmo José da Silva, que aos 53 anos de idade decidiu realizar um dos seus maiores sonhos, que era cursar a Universidade de Direito. O meu pai naquela altura passou por algumas dificuldades, mas ...

Global Research ab 20 June 2025 European Autos Chinese OEMs accelerating in Europe – time to be worried? Chinese brands comprise 6% market share now, even 11% in the EV segment Latest monthly data for the top-5 European markets show market share acceleration among Chinese brands, and we think further expansion in the coming months is likely on (1) even more price competition in the Chinese domestic market, ie, more profitable exports, (2) a potential replacement of EU EV import tariffs by minimum pricing, a ...

MELBOURNE, Australia and SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer of Alterity, will participate in a Fireside Chat hosted by MST Access on Wednesday, 25 June 2025 in Australia / Tuesday, 24 June 2025 in the United States. Dr. Stamler will provide a co ...

Core Viewpoint - Leading Edge Materials Corp. is positioning itself as a significant player in the European critical raw materials (CRM) sector, focusing on heavy rare earth elements (HREEs) and natural graphite amidst increasing geopolitical uncertainties and supply chain challenges [2][3][4]. Group 1: Industry Context - The G7 Critical Minerals Action Plan emphasizes the need for diversifying the production and supply of critical minerals, encouraging investments, and promoting innovation to protect economic and national security [3]. - Geopolitical tensions and reliance on China for HREE imports highlight the urgency for Europe to establish a secure and independent supply chain for critical minerals [12][13]. Group 2: Company Developments - Leading Edge Materials is advancing its Norra Kärr project, a globally significant source of HREEs, with production expected to start within 3-4 years [5]. - The company has received ownership and operational permits for the Avram Iancu mine in Romania, enhancing its operational autonomy and recognition of its investments in the region [6][7]. - The application for a new 25-year mining lease in Sweden is under consultation, with the company addressing feedback from County Administrative Boards regarding environmental impact assessments [9][10]. Group 3: Environmental and Community Engagement - The company is committed to sustainable mining practices, reducing the land area of its new application by 65% compared to the previous one, and ensuring chemical processing occurs off-site to mitigate pollution risks [13][14]. - Social acceptance and transparency towards the local community are prioritized in the development of the Norra Kärr project [13]. Group 4: Future Prospects - Pre-feasibility studies for Norra Kärr are underway, with promising results from testwork on mineralogy and chemical composition expected to inform market strategies [16]. - The Woxna Graphite mine is being evaluated for a potential restart, with ongoing tests aimed at optimizing graphite production [17][18]. - Exploration at the Bihor Sud project is progressing, with a focus on defining a large-scale, mineable mineral resource, particularly in promising areas for zinc-lead-copper-silver mineralization [19][20].

Just out of the corner of my eye, I see a couple of massive rockets which dominate the skyline here. Why doesn't Europe and its space industry dominate in the same way that that we see in the United States. What is it that we're not doing here, not funding here that we need to fund to be on par.I mean, I wouldn't say that Europe is not dominating. We have some of the programs that are the world's best programs that day. Earth Observation, the Copernicus program is delivering the largest amounts of data of o ...

Core Viewpoint - Apollo has signed an agreement to invest up to £4.5 billion in fixed-rate callable notes issued by Électricité de France (EDF) to primarily finance EDF projects in the UK, particularly the Hinkley Point C nuclear power station, marking one of the largest sterling-denominated note issuances on record [1][2]. Group 1: Investment Details - The investment will be used mainly for EDF projects in the UK, with a focus on the Hinkley Point C nuclear power station [1]. - This transaction is noted as the largest-ever capital funding transaction executed by EDF and the largest private credit transaction in the sterling market [2]. - Apollo has a history of investing in French companies, having provided €2.5 billion of High-Grade Capital Solutions to Air France-KLM in recent years [2]. Group 2: Apollo's Investment Strategy - Since 2020, Apollo has originated over $100 billion of bespoke capital solutions for leading companies, including Intel, Air France-KLM, BP, Sony, and AB InBev [3]. - Apollo aims to provide clients with excess returns across the risk-reward spectrum, from investment-grade credit to private equity [5]. Group 3: Legal and Financial Advisory - Latham & Watkins, LLP and Kirkland & Ellis LLP acted as legal counsel to Apollo, while Apollo Capital Solutions Europe B.V. provided structuring and arrangement services for the transaction [4]. - BNP Paribas and Hogan Lovells, LLP served as financial and legal advisors to EDF, respectively [4].